.svg)
Venture Medical Launches New Website!
.png)
We invite you to explore our brand new website
We’re excited to announce the launch of our brand-new website! 🎉
At Venture Medical, we’re committed to innovation—not just in wound care but also in how we connect with our clients, partners, and healthcare professionals. Our new website is designed to provide a seamless, user-friendly experience, making it easier than ever to explore our solutions, access key resources, and stay updated on the latest advancements in wound care.
With a fresh look, improved navigation, and enhanced functionality, our website reflects our dedication to excellence, accessibility, and customer service. Whether you’re a physician looking for industry-leading products or a healthcare provider interested in our Venture1View platform, everything you need is now just a click away.
We invite you to check out the new site and let us know what you think! 🚀
Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio
Venture Medical, LLC, a leader in wound care solutions, today announced its acquisition of certain assets of ProgenaCare Global, LLC, a biotechnology company known for its innovative, keratin-based wound healing technologies, including ProgenaMatrix®, along with intellectual property supporting an expected future product line. Howard Walthall, former CEO of ProgenaCare, has also joined Venture Medical as Senior Vice President of Product Development.
Venture Medical Announces Strategic Partnership with Plasmacure to Bring Groundbreaking Cold Plasma Therapy for Chronic Wounds to the U.S. Market
Venture Medical, LLC, a leading provider of advanced wound care solutions, is proud to announce a strategic development and distribution agreement in principle with Plasmacure B.V., the Netherlands-basedMedTech innovator behind the revolutionary PLASOMA cold plasma system for chronic wound treatment.
.png)
Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research
Open Wound Research and Venture Medical, LLC have entered into a collaborative research agreement to advance the study of pressure ulcer treatment. As part of this partnership, Venture Medical has acquired extensive pressure ulcer data from Open Wound Research to evaluate the efficacy of CAMPS in comparison to standard of care (SOC) treatments.
John Schroeder and Jason Matuszewski Give Presentation At CAMPS 2025
Last week at CAMPS 2025, John Schroeder, CEO of Venture Medical, and Jason Matuszewski, CEO of BioStem Technology, took the stage to deliver a compelling presentation titled “Why You Should Care About Investors in the Wound Care Space.”
